AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Delve into the field of PARP inhibitors, a class that has gained traction in ovarian, breast, and prostate cancers.

VCs and universities struggle with different goals and timelines, but tech transfer is helping turn academic science into ...

Phage therapy is emerging as a potential solution to antibiotic resistance and superbugs, with clinical advances in ...

Discover what were the top biotech deals that were signed in March 2026. From small molecules to antibodies, M&A activity was high.

Delve into the pipeline strategy of major biotech Amgen, which is increasingly diversifying its growth engines.

Atopic dermatitis is a chronic, relapsing inflammatory skin disorder characterized by eczematous lesions and intense itchiness, which can substantially impair an individual’s quality of life. Over the ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

The ongoing controversy involving WuXi AppTec, a prominent Chinese pharmaceutical and biotechnology contract development and manufacturing organization (CDMO), has sent ripples through both ...

As one of the top Ivy League schools in the U.S., Harvard University’s academic prestige is recognized all over the world. Among its many graduate programs, the university offers students the ...